The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers (Clinical Trial Phase I)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20150917001

Enrollment

Registered

2015-09-17

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee Sahastara remedy&#44

Interventions

The Sahastara remedy alcholic extract capsule dose 100 mg.,The Sahastara remedy alcholic extract capsule dose 200 mg.

Experimental Drug,Experimental Drug

100 mg SHT extract,200 mg SHT extract

Eligibility

Sex/Gender

All

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Both sex age between 20-45 years 2. No pregnancy 3. No Serious Medical Condition evaluated by Physical Examination and Laboratory results in 1 month before study 4. No Supplementary and/or Vitamin during the study 5. Able to follow suggestion during the study

Exclusion criteria

Exclusion criteria: 1. Have uncontrolled Hypertension (BP>140/90) 2. BMI > 30 3. Have Serious Medical condition such as Serious Peptic Ulcer, Congestive hearth disease, liver and renal dysfunction 4. On during use medicine including rifampicin, phynytoin, Propranolol, Theophylline 5. Hypersensitivity on herbal medicine

Design outcomes

Primary

Measure	Time frame
Clinical safety 28 days while using intervention and 14 days after intervention Physical Examination and Laboratory results	—

Secondary

Measure	Time frame
Pain score 48 hours Verbal numerating rating scale,Total morphine consumption 48 hours Mg	—

Countries

Thailand

Contacts

Public ContactPuritat Kanokkangsadal

Faculty of Medicine, Thammasat University

fire_pyro99@yahoo.com+6681-7323241

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026